Exelixis, Inc. (EXEL)
69.84
-0.86
(-1.22%)
USD |
NASDAQ |
Nov 12, 16:00
70.01
+0.17
(+0.24%)
After-Hours: 07:52
Exelixis Total Assets (Quarterly) : 2.513B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.513B |
| June 30, 2026 | 2.494B |
| March 31, 2026 | 2.594B |
| December 31, 2025 | 2.882B |
| September 30, 2025 | 2.824B |
| June 30, 2025 | 2.678B |
| March 31, 2025 | 2.837B |
| December 31, 2024 | 2.987B |
| September 30, 2024 | 2.960B |
| June 30, 2024 | 2.773B |
| March 31, 2024 | 2.804B |
| December 31, 2023 | 2.996B |
| September 30, 2023 | 2.977B |
| June 30, 2023 | 3.142B |
| March 31, 2023 | 3.143B |
| December 31, 2022 | 3.071B |
| September 30, 2022 | 2.961B |
| June 30, 2022 | 2.881B |
| March 31, 2022 | 2.654B |
| December 31, 2021 | 2.616B |
| September 30, 2021 | 2.448B |
| June 30, 2021 | 2.367B |
| March 31, 2021 | 2.191B |
| December 31, 2020 | 2.148B |
| September 30, 2020 | 2.111B |
| Date | Value |
|---|---|
| June 30, 2020 | 2.047B |
| March 31, 2020 | 1.956B |
| December 31, 2019 | 1.895B |
| September 30, 2019 | 1.785B |
| June 30, 2019 | 1.643B |
| March 31, 2019 | 1.542B |
| December 31, 2018 | 1.424B |
| September 30, 2018 | 1.024B |
| June 30, 2018 | 911.16M |
| March 31, 2018 | 774.92M |
| December 31, 2017 | 655.29M |
| September 30, 2017 | 609.77M |
| June 30, 2017 | 516.53M |
| March 31, 2017 | 586.98M |
| December 31, 2016 | 597.54M |
| September 30, 2016 | 548.49M |
| June 30, 2016 | 477.14M |
| March 31, 2016 | 492.53M |
| December 31, 2015 | 332.34M |
| September 30, 2015 | 363.24M |
| June 30, 2015 | 248.78M |
| March 31, 2015 | 282.93M |
| December 31, 2014 | 327.96M |
| September 30, 2014 | 383.66M |
| June 30, 2014 | 440.64M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 11.57B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Cytokinetics, Inc. | 1.825B |
| Gilead Sciences, Inc. | 51.41B |
| Ionis Pharmaceuticals, Inc. | 2.913B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 679.66M |
| Shareholders Equity (Quarterly) | 1.834B |
| Debt to Equity Ratio | 0.0884 |
| Current Ratio | 3.209 |
| Net Debt Paydown Yield | 0.02% |